871720-04-6

Basic information

• Product Name: AcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-
• Synonyms: AcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-;(R)-N-[1-(4-Bromo-phenyl)-ethyl]-2,2,2-trifluoro-acetamide
• CAS NO: 871720-04-6
• Molecular Formula: C10H9BrF3NO
• Molecular Weight: 296.0837696
• Mol File: 871720-04-6.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• CAS DataBase Reference: AcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-(CAS DataBase Reference)
• NIST Chemistry Reference: AcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-(871720-04-6)
• EPA Substance Registry System: AcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-(871720-04-6)

Safety Data

• Hazardous Substances Data: 871720-04-6(Hazardous Substances Data)

Upstream product

• 2354-91-8 (S)-2,2,2-trifluoro-(α-methylbenzyl)acetamide 
• 27298-97-1 (S)-1-(4-bromophenyl)ethylamine 
• 407-25-0 trifluoroacetic anhydride 
• 2627-86-3 (S)-1-phenyl-ethylamine 
• 147169-48-0 (S)-tert-butyl 1-phenylethylcarbamate 
• 912341-95-8 N-[1-(4-bromo-phenyl)-vinyl]-2,2,2-trifluoro-acetamide 
• 59862-55-4 p-bromoacetophenone oxime 
• 99-90-1 para-bromoacetophenone 
• 24358-62-1 1-(4-bromophenyl)ethylamine 
• 618-36-0 rac-methylbenzylamine 
• 24358-62-1 (R)-1-(4-bromophenyl)ethylamine 
• 2354-91-8 N-<(R)-(+)-α-phenylethyl>-2,2,2-trifluoroacetamide 
• 76-05-1 trifluoroacetic acid 
• 3886-69-9 (R)-1-phenyl-ethyl-amine 

Downstream Products

• 639514-37-7 C₂₁H₂₁ClN₂O₃S 
• 639514-51-5 C₂₁H₁₉ClN₂O₄S 
• 639514-61-7 C₂₁H₂₀ClN₃O₄S 
• 639514-48-0 C₂₁H₁₉ClN₂O₅S₂ 

Relevant articles and documents

Methylpyrazole derivatives as RET inhibitor

The invention relates to a methylpyrazole derivative as an RET inhibitor, in particular to a compound as shown in a formula (I), a stereoisomer and pharmaceutically acceptable salt thereof, a preparation method and a pharmaceutical composition thereof. The compound of the formula (I) can be used for preventing or treating diseases mediated by abnormal RET activity.

PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE

Disclosed are pyrazolo[3,4-b]pyridine and pyrrolo[2,3-b]pyridine inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are described, alone or in combin

Substituent effects on chiral resolutions of derivatized 1-phenylalkylamines by heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin GC stationary phase

Chiral resolutions of trifluoroacetyl-derivatized 1-phenylalkylamines with different type and position of substituent were investigated by capillary gas chromatography by using heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin diluted in OV-1701 as a chiral stationary phase. The influence of column temperature on retention and enantioselectivity was examined. All enantiomers of meta-substituted analytes as well as fluoro-substituted analytes could be resolved. Temperature had a favorable influence on enantioselectivity for small amines with substituents at the ortho-position. The type of substituent at the stereogenic center of amines also had a crucial effect as the ethyl group led to poor enantioseparation. Among all analytes studied, trifluoroacetyl-derivatized 1-(2′-fluorophenyl)ethylamine exhibited baseline resolution with the shortest analysis time.